Houston Texans rookie receiver John Metchie III revealed a recent diagnosis of leukemia on Sunday and said he expects to miss the 2022 season as he focuses on treatment and recovery.
“Recently I was diagnosed with APL (acute promyelocytic leukemia), the most curable form of leukemia,” Metchie, 22, said. said in a press release posted on the Texans’ Twitter account. “I am currently receiving excellent medical care, I am in good spirits and I expect to recover later. As a result of this diagnosis, I will probably not play football this season.
“My main focus will be my health and recovery. Thank you in advance for your support and best wishes. I look forward to coming back stronger than ever. God bless you.”
NEW OFFER:Lamar Jackson bet on himself, now Ravens have to pay | Opinion
NFL TRAINING CAMPS: Everything you need to know as a player report
NFL NEWSLETTER: Sign up now to get football news delivered to your inbox
In a corresponding move, the Texans announced later Sunday that they had placed Metchie on the active/non-football sick list.
Metchie was a second-round pick in the 2022 NFL Draft, taken with the No. 44 overall pick. He played at Alabama, where he caught 155 passes for 2,081 yards and 14 touchdowns in 30 games for the Crimson Tide.
Metchie was already dealing with another medical issue, after suffering a torn anterior cruciate ligament in the SEC Championship game, Alabama’s 41-24 win over Georgia, on Dec. 4, 2021. Metchie had caught six assists for 97 yards and a score in the first half before being injured.
“John overcame every challenge placed before him in his life with tenacity and determination, and we are behind him every step of the way in his battle with leukemia,” said Crimson Tide coach Nick Saban. said in a statement on Sunday. “It is a blessing that he is in a city known for excellent medical care and with an organization, the Houston Texans, who will be with him on this journey. Our thoughts and prayers will be with him throughout. throughout this battle.”
Metchie, a native of Brompton, Ontario, Canada, was diagnosed with an enlarged heart in high school but was later cleared to play football. He was expected to bring an infusion of speed and athleticism to a roster of Texans that is rebuilding and vying for a starting spot in Houston’s offense.
Houston has faced similar adversity before, as former offensive lineman David Quessenberry underwent treatment in 2014 after being diagnosed with non-Hodgkin’s T-cell lymphoblastic lymphoma.